The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Apr 2020 11:30

RNS Number : 1647L
Grafenia plc
28 April 2020
 

28 April 2020

 

Grafenia plc

 

("Grafenia", the "Group" or "Company")

 

Share Stake Scheme and Director/PDMR notification

 

Grafenia (AIM: GRA) announces the launch of a new Share Stake Scheme (the "Scheme"). This allows team members to elect to forgo a proportion of their remuneration receivable from the Company, in return for the receipt of new ordinary shares of one penny each in the Company ("New Ordinary Shares").

 

All of the Executive Directors have elected to receive between 20% and 30% of their monthly net remuneration in New Ordinary Shares from 1 April 2020 for a period of seven months. Non Executive Directors have elected to receive 100% of their fees in New Ordinary Shares for the same period. The Company's Chairman, Jan-Hendrik Mohr, has also donated his fee to "The Chairman's Seam Team Fund" for the same period.

 

The total number of New Ordinary Shares that will be issued to Directors under the Scheme is 649,310, representing 0.57% of the Company's enlarged issued share capital.

 

Jan-Hendrik Mohr, said "Since the outbreak of the pandemic, our teams have been working hard to support our clients, partners and each other. We've launched new products and initiatives in an attempt to help. Last week, we launched www.animasks.co.uk - a range of stylish animal face covers. We're donating 100% of all sales proceeds to NHS Charities. Today I'm announcing The Chairman's Seam Team Fund. I'm donating my director's fee to support the fund. The fund will provide up to 100 sewing machines to seamsters who have been furloughed or made redundant because of Coronavirus. We're asking people who can sew to volunteer to the cause. To make AniMasks and support the NHS by visiting www.animasks.co.uk/volunteer "

 

Team members are also now being invited to participate in the Scheme. It provides members of the Grafenia team the opportunity to become shareholders, or increase their existing shareholdings, whilst also enabling the Company to conserve cash resources during the ongoing COVID-19 crisis.

 

Peter Gunning, CEO of Grafenia said "Leadership Value #14 for our team members is 'Think like an owner'. The best way we know to achieve this is actually becoming an owner, as a shareholder. Many team members participated in our 3 year Save-as-you-Earn scheme, which matured last month. The timing of that wasn't great, to say the least. So, we're inviting team members to become Grafenia shareholders a different way. Those that are helping the Company conserve cash at the moment, will hopefully be rewarded when we come out the other side."

 

All New Ordinary Shares in respect of the Scheme will be issued in December 2020, at a price of 7.75p per share, which is above the current market price and the same as the exercise price of share options, which matured under the Company's Save as You Earn share scheme on 1 March 2020.

 

The total number of New Ordinary Shares that may be issued under the Scheme is capped at 3,000,000, representing 2.6% of the Company's enlarged issued share capital. The final number of New Ordinary Shares to be issued will depend on the level of participation in the Scheme by currently non-furloughed employees and potential additional participation by employees returning from furlough leave. The final number of New Ordinary Shares to be issued in respect of the Scheme will be announced in December 2020, along with the Directors' resulting percentage shareholdings.

 

Further details and the information required in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 are set out at the end of this announcement.

 

Grafenia plc

Peter Gunning (Chief Executive Officer)

07973 191 632

Allenby Capital Limited (Nominated Adviser and broker)

David Hart / Liz Kirchner / Nicholas Chambers

0203 328 5656

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

PDMRs:

Peter Gunning

Chief Executive Officer

Iain Brown

Group Finance Director

Gavin Cockerill

Chief Operating Officer

Conrad Bona

Non-Executive Director

Simon Barrell

Non-Executive Director

Richard Lightfoot

Director & Company Secretary

2.

Reason for the Notification

a)

Position/status

See 1a) above

b)

Initial notification/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Grafenia plc

b)

LEI

213800OKTI2518K5KM22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 Ordinary shares of 1p each in Grafenia plc

Identification code

GB0009638130

b)

Nature of the transaction

Acquisition of Ordinary Shares in lieu of a proportion of remuneration (Share Stake Scheme).

c)

Price(s) and volume(s)

Price: 7.75p

Volumes:

Peter Gunning

231,355

Iain Brown

84,208

Gavin Cockerill

87,644

Conrad Bona

83,588

Simon Barrell

85,358

Richard Lightfoot

77,166

d)

Aggregated information:

Aggregated volume

Price

n/a

e)

Date of the transaction

28 April 2020

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUPPCUPUGUR
Date   Source Headline
17th Oct 20237:00 amRNSChange of Company name effective
16th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20239:37 amRNSGrant of options
26th Sep 202312:21 pmRNSResult of AGM and Change of Name and Website
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20235:39 pmRNSHolding(s) in Company
15th Sep 20235:47 pmRNSReplacement: Result of GM and Open Offer
15th Sep 202310:22 amRNSResult of General Meeting and Open Offer
8th Sep 20232:03 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSFundraise of up to £27.9 million and other matters
26th Jul 20237:00 amRNSFinal Results
1st Jun 20237:00 amRNSUpdate re. the sale of Works Manchester Limited
3rd May 20237:00 amRNSPre-close statement and Trading Update
3rd Apr 20231:13 pmRNSHolding(s) in Company
17th Feb 202312:35 pmRNSAcquisition of Topfloor Systems Limited
20th Jan 20232:49 pmRNSBond Issue
18th Jan 20237:00 amRNSAcquisition of Care Management Systems Limited
28th Dec 20227:00 amRNSHolding(s) in Company
13th Dec 20227:00 amRNSReplacement: Bond Issue
12th Dec 20225:51 pmRNSBond Issue
7th Dec 20225:07 pmRNSAcquisition of Watermark Technologies Limited
24th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSBoard Appointment
7th Oct 202211:37 amRNSHolding(s) in Company
6th Oct 20221:48 pmRNSHolding(s) in Company
27th Sep 202212:56 pmRNSBond Issue
22nd Sep 20224:09 pmRNSAcquisition of Vertical Plus Limited
14th Sep 20222:18 pmRNSResult of AGM
27th Jul 20223:18 pmRNSReplacement: Final Results
27th Jul 20227:00 amRNSFinal Results
19th May 20227:00 amRNSSale of Subsidiary and Board Changes
4th May 20229:01 amRNSDirector/PDMR Shareholding
6th Apr 202212:00 pmRNSPre-close statement and Trading Update
22nd Nov 20217:00 amRNSHalf-year Report
15th Sep 202110:35 amRNSResult of AGM
15th Sep 20217:00 amRNSAGM Trading Statement
28th Jul 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSPre-close Trading and Strategy Update
3rd Mar 20217:00 amRNSBlock admission review & block cancellation
8th Jan 202112:38 pmRNSStmnt re Share Price Movement
31st Dec 20201:00 pmRNSTotal Voting Rights
14th Dec 20203:45 pmRNSIssue of Equity re Share Stake Scheme
25th Nov 20207:00 amRNSHalf-year Report
22nd Sep 202011:31 amRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Trading Statement and Acquisition Update
3rd Sep 20207:00 amRNSBlock listing Interim Review
1st Sep 20207:00 amRNSReplacement: Final Results
12th Aug 20207:00 amRNSFinal Results
24th Jul 202012:37 pmRNSReplacement: Bond Facility & trading update
15th Jul 202010:45 amRNSBond Facility for up to £50m & trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.